ライフサイエンスコーパス: i.v.

1 nal cortisol infusion (1.2 mg kg(-1) day(-1) i.v. for 5 days, n = 20) on fetal glucose, lactate and o

2 ty was rejected as CL316,243 (0.15 mg kg(-1) i.v.) evoked similar rises in oxygen consumption (VO2) i

3 rial lipopolysaccharide (LPS, 500 mug kg(-1) i.v.) in rats at an ambient temperature of 22 degrees C.

4 (-1) i.v. dopamine, (3) 10 ug kg(-1) min(-1) i.v. dobutamine, and (4) following creation of an intra-

5 ns: (1) at baseline, (2) 2 ug kg(-1) min(-1) i.v. dopamine, (3) 10 ug kg(-1) min(-1) i.v. dobutamine,

6 The aim of the AIDA STEMI (Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction)

7 Antibiotics administered i.v. did not prevent dissemination into the peritoneum o

8 ium-based contrast agent can be administered i.v. to the animal to detect mural inflammation or tumor

9 .c. HT-1080 tumors in nude mice administered i.v. docetaxel-containing nanoparticles was more effecti

10 However, the majority of MSCs administered i.v. encounter a pulmonary impasse and soon disappear fr

11 at a dose of 9.0 x 10(5) PfSPZ administered i.v. three times at 8-wk intervals to 15 malaria-naive a

12 Four rhesus monkeys self-administered i.v. infusions of fentanyl (0.00032 mg/kg/infusion) or c

13 Paclitaxel was administered i.v. at 50 mg/m and i.p. at 20 mg/m on days 1 and 8.

14 Imprime (4 mg/kg) was administered i.v. in single and multiple infusions.

15 ConA was administered i.v. to control or HSC-depleted mice; hepatic histopatho

16 h a mean diameter of 83 nm were administered i.v. in hamsters.

17 s were experimentally seeded via an adoptive i.v. transfer of luciferase-expressing CT26 CRC cells th

18 After i.v. administration in C57BL/6 mice, we observed marked

19 After i.v. injection of CLM, its nanoscale size and stimuli-re

20 After i.v. or s.c. priming, partial proliferation and activati

21 nism, but the antinociceptive activity after i.v. administration could not be directly correlated to

22 ycosylation was essential for activity after i.v. administration.

23 s computed tomography (CT), before and after i.v. contrast media enhancement.

24 acquisitions were performed before and after i.v. or intrapulmonary administration of the nanoparticl

25 on, the amount of accumulated antibody after i.v. application was calculated relative to its apoptosi

26 um concentration obtained in the blood after i.v. administration correlates with body weight across a

27 The mean t1/2 of KRN23 was 8-12 days after i.v. administration and 13-19 days after s.c. administra

28 late in the wound margins several days after i.v. administration.

29 1, ELDP and CT-proET-1 were determined after i.v. injection in anaesthetised rats.

30 cell line showed transgene expression after i.v. CPS injection in an animal model of metastasis.

31 levels of effector cytokines in hosts after i.v. AML induction, consistent with abortive T cell acti

32 4.7 T before, during and up to 60 min after i.v. injection of EP-3533, or of its non-binding isomer

33 ssue rapidly and homogeneously; 30 min after i.v. injection, siRNA-L2 achieved uptake in 99% of tumor

34 Bacteria were captured within minutes after i.v. injection and were associated with Mphis in both li

35 schemia reperfusion injury mouse model after i.v. injection confirms the ability of injected neutroph

36 MRI and optical imaging were performed after i.v. injection of the liposomal nanoprobes into mice bea

37 s spectrometry (ICP-MS), respectively, after i.v. injection of the payload loaded HA NPs in tumor bea

38 nal centers (GCs), and the Ab response after i.v. administration of IgG3 anti-trinitrophenyl (TNP) in

39 illary endothelial cells in the retina after i.v. application.

40 e antigen to erythrocyte cell surfaces after i.v. injection, one using a conjugate with an erythrocyt

41 nized mice were completely protected against i.v. Stx2 challenge, and weaned mice receiving an oral c

42 ere we report significant protection against i.v. acquisition of SIVmac239 using a long-lasting appro

43 netics and immune responses induced after an i.v. infection with a Brazilian ZIKV clinical isolate (H

44 hol cue-exposure session (day 6; AM), and an i.v. alcohol administration session (day 6; PM).

45 n the legs of mice followed 3 wk later by an i.v. exposure to Staphylococcus aureus This procedure re

46 ability to protect pigtail macaques from an i.v. high-dose cell-associated SHIVSF162P3 challenge.

47 The dendribodies were administered in an i.v. bolus to male Sprague Dawley rats after starting a

48 time each active lever press resulted in an i.v. cocaine infusion paired with one of two cues that a

49 ich time active lever presses resulted in an i.v. infusion of cocaine that was paired with a light/to

50 Imprime PGG (Imprime) is an i.v. administered, yeast beta-1,3/1,6 glucan in clinical

51 unized and five control subjects received an i.v. challenge with P. falciparum-infected erythrocytes.

52 w paradigm in the treatment of PAH, using an i.v./sublingual tissue-penetrating homing peptide to sel

53 ective role, we studied both aerosolized and i.v. models of mycobacterial infection and observed MIF-

54 everal volatile (isoflurane, desflurane) and i.v. (propofol) general anesthetics excite peripheral se

55 of immune suppression to more frequently and i.v. administered licensed therapies.

56 ortant finding is that both intratumoral and i.v. administration demonstrated a significant enhanceme

57 mmed death ligand 1 binding site just before i.v. injection of IgM/LPS-pretreated BMDC or using IL-10

58 cer cell lines with anti-CD73 AD2 mAb before i.v. injection into mice inhibited extravasation/coloniz

59 Both i.v. hexamethonium and locally applied prazosin abolishe

60 erum, and up to 70% were protected from both i.v. and mosquito bite challenge with transgenic Plasmod

61 e, results in significant protection in both i.v. and airway-induced models of IA.

62 ntation of in vivo-formed Ag-Ab complexes by i.v. injecting mice with Ag-specific Abs followed by the

63 llers with low viremia) were CD8 depleted by i.v. administration of the antibody M-T807R1.

64 Retinal vessels were labelled by i.v. injection of a fluorescent dye and imaged with scan

65 levels of corticosterone were normalized by i.v. leptin infusion at a dose that raises low plasma le

66 The second hypoxic exposure was preceded by i.v. infusion of iron.

67 CM4620 administration to rats by i.v. infusion starting 30 min after induction of pancrea

68 mportantly, this loss is swiftly restored by i.v. administration of human recombinant ANXA1.

69 PAH was prevented and reversed by i.v. iron and by the ET receptor antagonist BQ-123.

70 us aureus implant infections were treated by i.v. administration of activated or non-activated MSC, w

71 NV infection, we administered exogenous CCL7 i.v. to WNV-infected Ccl7(-/-) mice and observed a signi

72 In this study, we compared i.v. and foodborne transmission of L. monocytogenes in m

73 ced septic acute kidney injury by continuous i.v. infusion of Escherichia coli.

74 Macrophage depletion was achieved by daily i.v. clodronate liposomes (-1 day to +3 days) during Ang

75 t up to 0.20% to 0.97% of antibody delivered i.v. reached the brain tumor, but that apoptosis inducti

76 ffected lung tumor growth in three different i.v. metastasis models.

77 High-dose i.v. Ig (IVIg) is a prominent immunomodulatory therapy f

78 High-dose i.v. Ig (IVIG) is used to treat various autoimmune and i

79 the anti-inflammatory effects of large-dose i.v. Ig (IVIg) in autoimmunity.

80 MyTrCa(-/-)) mice that succumbed to low-dose i.v. VSV infection with similar kinetics as IFN-I recept

81 f SIVmac239 following repeated marginal dose i.v. challenges over a 4-month period.

82 In the three-dose i.v. arm, 246/333 (74%) children had >/= 99% reduction i

83 ared both a three-dose i.m. and a three-dose i.v. parenteral ARS regimen with the standard five-dose

84 = 331; three-dose i.m.: n = 338; three-dose i.v.: n = 333); 139 participants were lost to follow-up.

85 Adoptive transfer (i.e., i.v. injection) of glycolipid (Ag)-loaded WT but not S1P

86 with ischemic AKI, administration of ECFCs (i.v.) at the time of reperfusion significantly attenuate

87 Garcinol administered after either i.v. or i.p. cocaine reactivation significantly decrease

88 rug memory was later reactivated with either i.v. or i.p. cocaine presentation in the absence of any

89 subjects underwent experimental endotoxemia (i.v. administration of 2 ng/kg Escherichia coli endotoxi

90 Administration of exosomes (i.v.) directly to mice with ischemic AKI attenuated rena

91 In fact, i.v. AML cell inoculation prevented functional T cell ac

92 Following i.v. peptide injection, in vivo Helios expression in ado

93 y superior compared with free drug following i.v. delivery, exploiting the "enhanced permeability and

94 d to 1.7% of injected dose at 24 h following i.v. delivery.

95 a fluorescent dye, illuminated MB following i.v. injection and was able to distribute throughout the

96 t to the spleen, were all observed following i.v. but not foodborne transmission of L. monocytogenes.

97 ntrauterine infection was observed following i.v. rhCMV inoculation during the early second trimester

98 half-life was 46.1 h in mini-pigs following i.v. administration, and semaglutide has an MRT of 63.6

99 ecific regulatory function in vivo following i.v. injection of non-T cells derived from the spleen of

100 , and significant triglyceride reduction for i.v.-injected TPP-HDL-apoA-I-QD NPs in rats.

101 available in vivo gene delivery formulation, i.v. delivery of the core/PEGylated shell (CPS) nanopart

102 lated with their in vivo Ag acquisition from i.v. injected Ag-loaded splenic non-T cells, and in vivo

103 ly protected mice with humanized livers from i.v.- and mosquito bite-delivered P. falciparum sporozoi

104 -/-) mice had impaired response to CpG given i.v. or s.c.

105 n with Abraxane(R) (12mg paclitaxel/kg given i.v.), ACT induced a strong increase in the therapeutic

106 when submitted to hyperglycemic (40% glucose i.v.) and hypoglycemic (5 U/kg insulin i.v.) challenges.

107 (10 and 20 mg/kg, 10 and 20 mg kg/h for 1 h, i.v.), pazopanib (30 and100 mg/kg, i.p.), or vandetanib

108 nib (3 and 6 mg/kg, 3 and 6 mg/kg/h for 1 h, i.v.), sorafenib (10 and 20 mg/kg, 10 and 20 mg kg/h for

109 f blast trauma with multiorgan hemorrhaging, i.v. administration of the hemostatic nanoparticles led

110 In subordinate monkeys, however, i.v. buspirone was ineffective on average, and oral busp

111 e in the anti-inflammatory activity of human i.v. immunoglobulin therapy.

112 Splenocytes from wild-type mice infected i.v. produced significantly more IFN-beta than did those

113 CR7) in mice that were subsequently infected i.v. with Listeria monocytogenes.

114 Mice were infected i.v. using 8 different S. aureus strains, and developmen

115 ter 5 days of recovery, mothers were infused i.v. for 30 min with either vehicle (n = 11), low dose (

116 Animals received an initial i.v. bolus of placebo, natalizumab (30 mg/kg), or vedoli

117 y charged microdroplet clusters are injected i.v., activated within the target pathology by diagnosti

118 on biased data collected with cells injected i.v., a route in which most transferred cells enter via

119 The radiotracers were injected i.v. into antigen-positive, antigen-negative, immunodefi

120 When breast tumor cells were injected i.v. into IL-15(-/-), C57BL/6, IL-15 transgenic (TG) and

121 e radiolabelled imaging probes were injected i.v. into wild-type, Sglt1(-/-) , Sglt2(-/-) and Glut2(-

122 scapular and suprarenal region were injected i.v. with 1 mg of TF12 and, after 16 hours of tumor accu

123 When injected i.v. in mice bearing CT26 colon carcinoma or B16 melanom

124 tered methamphetamine (0.03 mg/kg/injection, i.v.) under a fixed-ratio 20 schedule of reinforcement (

125 cell responses against AML cells inoculated i.v. versus s.c.

126 ucose i.v.) and hypoglycemic (5 U/kg insulin i.v.) challenges.

127 Intravenous (i.v.) anti-VCAM-1 or intraperitoneal (i.p.) beta7 blocki

128 himeric H77/JFH1 virus (HJ3-5), intravenous (i.v.) challenge with 10(6) FFU H77S.2 virus resulted in

129 body localization of NPs after intravenous (i.v.) injection into live mice bearing human lung tumors

130 s in the retina and brain after intravenous (i.v.) injection of infected monocytes or dendritic cells

131 e in vivo MSC persistence after intravenous (i.v.) injection.

132 n CSF following intrathecal and intravenous (i.v.) administration of ziconotide was investigated.

133 transmission efficiency between intravenous (i.v.) and i.c. routes to estimate dose-dependent TTvCJD

134 WHO-recommended regimen of five intravenous (i.v.) or i.m. injections over 4 d.

135 ry parent formulation following intravenous (i.v.) delivery.

136 ent (STING(-/-)) mice following intravenous (i.v.) infection.

137 ycoside moiety was required for intravenous (i.v.) but not for intracerebroventricular (i.c.v.) activ

138 ated with RvD1 (0.3 or 1 mug/kg intravenous (i.v.)) or vehicle (n = 7).

139 ction also extended to a lethal intravenous (i.v.) C. albicans challenge but had no effect in the C.

140 nce of C. neoformans in a mouse intravenous (i.v.) meningitis model.

141 al efficacy and tolerability of intravenous (i.v.) and intraperitoneal (i.p.) paclitaxel combined wit

142 a progressive-ratio schedule of intravenous (i.v.) drug injection.

143 d investigate the efficiency of intravenous (i.v.), intraperitoneal (i.p.), and intramuscular (i.m.)

144 1:1 to treatment with serelaxin intravenous (i.v.) infusion (for 60 min at 80 mug/kg/d and then 60 mi

145 titumor efficacy after systemic intravenous (i.v.) administration.

146 ied Carba NP test that utilized intravenous (i.v.) imipenem-cilastatin, which is less expensive than

147 ing elevated drug levels versus intravenous (i.v.) injection.

148 riphosphate (ATPgammaS) added intravenously (i.v.).

149 m or cationic or administered intravenously (i.v.) showed no TAM targeting.

150 cked C. albicans mutant given intravenously (i.v.) and S. aureus given intraperitoneally (i.p.) faile

151 hesus macaques (RMs) infected intravenously (i.v.) with SIVmac239.

152 into two groups and injected intravenously (i.v.) 6 hours post-MCAO with either 1 mg/kg PNU-120596 (

153 that underlie the ability of intravenously (i.v.) administered STING-NPs to induce STING activation

154 enged intratracheally (i.t.), intravenously (i.v.), or intraperitoneally (i.p.) with Escherichia coli

155 The animals were intravenously (i.v.) administered PGT121 or 3BNC117 at 10 and 2 mg/kg o

156 a clinically desirable therapy would involve i.v. infusion of a recombinant enzyme.

157 Current treatment of these attacks involves i.v. administration of hemin, but a faster-acting, more

158 ., NIR light exposure; group 4=cet-tra-IR700 i.v. and additional cet-tra-IR700 i.v. at 24h but no lig

159 -tra-IR700 i.v. and additional cet-tra-IR700 i.v. at 24h but no light exposure; group 5=cet-tra-IR700

160 light exposure and additional cet-tra-IR700 i.v. immediately after NIR but no additional NIR light e

161 but no light exposure; group 5=cet-tra-IR700 i.v., NIR light exposure and additional cet-tra-IR700 i.

162 v., no light exposure; group 3=cet-tra-IR700 i.v., NIR light exposure; group 4=cet-tra-IR700 i.v. and

163 group 1=no treatment; group 2=cet-tra-IR700 i.v., no light exposure; group 3=cet-tra-IR700 i.v., NIR

164 tion of an injection of placebo or 0.5 mg/kg i.v. methylphenidate.

165 eive a single dose of KRN23 (0.003-0.3 mg/kg i.v. or 0.1-1 mg/kg s.c.) or placebo.

166 ed T1/2 values of 1.1-1.2 h (dose of 5 mg/kg i.v.) and MTDs of 60-80 mg/kg (i.p.).

167 ly treated with artesunate (2.4 or 4.8 mg/kg i.v.) or vehicle upon resuscitation.

168 sepsis, the administration of LXA4 (7 mug/kg i.v.) 1 h after surgery increased neutrophil phagocytic

169 apomorphine (100-200 ug/kg i.p. or 20 ug/kg i.v.) administration, suggesting that it was not due to

170 days, received an insulin bolus (10 units/kg i.v.) plus insulin infusion (50 mU/kg/min i.v.) until hy

171 (KOR) agonist salvinorin A (0.01-1.8 mg/kg, i.v.) before administration of the KOR selective radiotr

172 i.m.) attenuated cocaine-induced (1.0 mg/kg, i.v.) dopamine overflow in the caudate nucleus but not i

173 istering subanesthetic ketamine (1-30 mg/kg, i.v.) or vehicle to conscious rats (n=12) and testing th

174 at brain demonstrated that 4-MEC (1-3 mg/kg, i.v.) produced large increases in extracellular 5-HT, sm

175 In contrast, 4-MePPP (1-3 mg/kg, i.v.) produced selective increases in dopamine and robus

176 single daily cocaine-reinforced (1.0 mg/kg, i.v.) runway trials 10 min after intracranial injection

177 24 h after amphetamine infusion (0.56 mg/kg, i.v.).

178 cotinic receptors by hexamethonium (3 mg/kg, i.v.).

179 on for earning cocaine infusions (0.3 mg/kg, i.v.).

180 pha2-AR agonists dexmedetomidine (25 mug/kg, i.v.) and clonidine (100 mug/kg, i.v.) inhibited shiveri

181 The effects of CP 55 940 (1.0-10 mug/kg, i.v.) and THC (3.0-300 mug/kg, i.v.) on food-maintained

182 (25 mug/kg, i.v.) and clonidine (100 mug/kg, i.v.) inhibited shivering EMGs, BAT SNA, and BAT thermog

183 .0-10 mug/kg, i.v.) and THC (3.0-300 mug/kg, i.v.) on food-maintained responding and body temperature

184 olidine methiodide (nicotine(PM), 30 mug/kg, i.v.) resulted in habituation (tolerance) of the same ph

185 human annexin A5 treatment (5 or 10 mug/kg, i.v.).

186 to a low, pyrogenic dose of LPS (10 mug/kg, i.v.).

187 gh, shock-inducing dose of LPS (5000 mug/kg, i.v.); this attenuation was due to a blockade of cold-se

188 uated ACTH responses to IL-1beta (500 ng/kg, i.v.) in PNS females, but not in PNS males.

189 LPS (1.0 ng/kg, i.v.) was administered 180 min before the second [11C]PB

190 Aspirin (10 mg/kg; i.v.) inhibited COX-1, measured as blood thromboxane and

191 at 30 mug/kg/d) or terlipressin (single 2-mg i.v. bolus), and the regional hemodynamic effects were q

192 del plasma and in plasma from wild-type mice i.v. injected with Abeta42.

193 kg i.v.) plus insulin infusion (50 mU/kg/min i.v.) until hypoglycemia ensued (</=3.9 mmol/L) (experim

194 n = 7) or SSTR2a infusion (3,000 nmol/kg/min i.v., n = 12) 60 min prior to the same insulin regimen.

195 Moreover, i.v. injection of FB28.4.2 in rats blocked complement ac

196 In a mouse i.v. infection model, antibody-mediated platelet depleti

197 s in contrast to single IA (sIA) or multiple i.v. (mIV) injections of relaxin-2 with which the ROM re

198 Liposome administration s.c., but not i.v., induced ChgA-specific Foxp3(+) and Foxp3(-) PD1(+)

199 erated against AML cells after s.c., but not i.v., inoculation.

200 f the profound tolerance-inducing ability of i.v. administered Ag-coupled splenocytes (Ag-SP) in mice

201 associate odor cues with the availability of i.v. cocaine or oral sucrose, respectively.

202 ly enhance the pulmonary vascular effects of i.v. vasodilators in Sugen5416/hypoxia/normoxia-exposed

203 d pericyte coverage and decreased leakage of i.v.-administered Texas Red-conjugated dextran.

204 At day 7, another injection of 10 mug of i.v. TDM in oil/water emulsion was given (TDM-IV).

205 The number of i.v. sedations performed in residency was moderately cor

206 was moderately correlated with the number of i.v. sedations personally performed in periodontal pract

207 cokinetics, pharmacodynamics, and potency of i.v. administrations in healthy subjects.

208 This pattern was observed regardless of i.v. contrast medium type, diagnostic criteria for AKI,

209 te an increasing use of high-dose therapy of i.v. gammaglobulin (IVIg) in the treatment of various T

210 half (49.8%) of the survey respondents offer i.v. sedation in their practices.

211 ivided into 3 groups: control (group 1), one i.v. bolus DNase I before CPB start (group 2) and a seco

212 at 0, 24, and 48 h) either i.m. (n = 348) or i.v. (n = 351), both of which were the intervention arms

213 ed whether tumor cells were injected s.c. or i.v. and independently of the injection route of the hUC

214 After orotracheal or i.v. administration of USRPs, an excellent colocalizatio

215 In ovo i.v. injection of PE resulted in deletion of VLR(PE)Tmu-

216 The i.p./i.v. TDM (TDM-IVIP) group was compared with mice injecte

217 y assigned to receive either 50 mg pethidine i.v. (n = 48), or an equal volume of 0.9% normal saline

218 in the liver and 42% in the kidneys 16h post i.v. injection.

219 In rats, i.v. ANG2002 induced a dose-dependent analgesia in the f

220 ial adverse event in NPC1 patients receiving i.v. cyclodextrin therapy.

221 a phase II study, with 22 patients receiving i.v. mangafodipir following oxaliplatin.

222 Furthermore, repeat i.v. administration of h-alpha-Gal A mRNA showed a susta

223 n Pd1-/- mice were recapitulated by repeated i.v. applications of nivolumab in WT mice, even though n

224 acteria and wound healing following repeated i.v. administration of activated allogeneic canine MSC.

225 nt OVA TCR transgenic (OT-II) mice or saline i.v. 48 h before challenge with aerosolized OVA.

226 in data obtained during a frequently sampled i.v. glucose tolerance test showed that the antidiabetic

227 relapsed HL were evaluated with up to seven i.v. infusions of the radiolabeled anti-CD25 antibody (9

228 A single i.v. dose of Alas1-siRNA prevented the phenobarbital-ind

229 ee groups of mice were treated with a single i.v. injection of rAvPAL-RBCs at three different doses t

230 re examined a model without injury; a single i.v. injection of unfractionated BMCs in healthy mice.

231 d immunogenicity of KRN23 following a single i.v. or s.c. dose of KRN23 in adults with XLH.

232 ynamic stress via sodium nitroprusside (SNP) i.v.] on stimulus evoked responses of sensory processing

233 urnover under post-absorptive and fed state (i.v. Glamin to double amino acids, dextrose to sustain g

234 In microdialysis studies i.v. PRE-084 did not significantly stimulate dopamine at

235 In this study, i.v. administered poly(lactide-coglycolide) nanoparticle

236 detailed account is provided for successful i.v. administration of SERRS nanoparticles such that del

237 o experiments were carried out upon systemic i.v. injections with anti-CD137 mAbs and showed CD137 in

238 munized human MUC1 transgenic mice (MUC1.Tg) i.v. with a MUC1 peptide vaccine against which they gene

239 amma, and monokine induced by IFN-gamma than i.v. challenged controls.

240 In addition, we demonstrate that i.v. infusion of the isolated EVs shortly after inductio

241 We found that i.v. administration of the anti-CD40Ab induced rapid and

242 We show that i.v. administration of these NPs can target WAT vasculat

243 ialysis in rat nucleus accumbens showed that i.v. administration of 0.3 and 1.0 mg/kg of mephedrone o

244 the tumor Ag MUC1, we previously showed that i.v. immunization of MUC1 transgenic mice, but not wild-

245 We report in this study that i.v. delivery of rhabdoviral vectors leads to direct inf

246 The i.v. administration of clodronate effectively reduced to

247 The i.v. administration of HBD3/CpG complexes induced proinf

248 The i.v. injection of HoxB8 progenitors into lethally irradi

249 The i.v. injection of oxygen bubbles has recently emerged as

250 The i.v. injection of thrombin-activated platelets into CD40

251 The i.v. use of drugs transmits bloodborne pathogens, partic

252 consequence of infection of marmosets by the i.v. and s.c. exposure routes.

253 table role in mediating host survival by the i.v. route was not recapitulated following a mucosal inf

254 s routinely lethal to STING(-/-) mice by the i.v. route.

255 o L. monocytogenes may be an artifact of the i.v. infection model.

256 n this phase 1b trial, we concluded that the i.v. administration of peptide-loaded dendritic cells is

257 Administration of T4(+) T cells using the i.v. or intratumoral routes achieves partial tumor regre

258 s a higher bioavailability compared with the i.v. administration of the commercial docetaxel solution

259 We added stable isotope-labeled threonine i.v. to mice and combined fluorescence in situ hybridiza

260 with the addition of aerosolized colistin to i.v. treatment, whereas the addition of aerosolized coli

261 ntranasal administration (15min) compared to i.v. administration (120min).

262 the incidence of AKI in patients exposed to i.v. contrast medium was directly compared with the inci

263 y cortex of anesthetized mice in response to i.v. NH4(+).

264 or rapid TNF-alpha and IFN-beta responses to i.v.-injected sialylated C. jejuni.

265 erosolized colistin as adjunctive therapy to i.v. antimicrobials or as monotherapy in the treatment o

266 ne (4get) or Cd45.1 allele was used to track i.v. transferred eosinophils into the airway following a

267 Accordingly, when infected mice were treated i.v. with an MHC-II-restricted M. tuberculosis epitope p

268 a consequence of STING activation in tumors, i.v. administered STING-NPs reprogram the TME towards a

269 icant tumor gene silencing for 7 d after two i.v. doses.

270 ces spleen and bone marrow tumor burden upon i.v. leukemic engraftment.

271 capillaris and intraretinal capillaries upon i.v. injection and 1-h circulation time.

272 In this article, we report that upon i.v. transfer (to avoid major iatrogenic interference),

273 Propofol, a widely used i.v. anesthetic, has been shown to modulate immunoinflam

274 Propofol is the most widely used i.v. general anesthetic to induce and maintain anesthesi

275 Contrary to what was observed using i.v. infection, IFNAR1(-/-) and wild-type mice had simil

276 he largest percentage of periodontists using i.v. sedation (74.0%) was reported from American Academy

277 were comparing adjunctive aerosolized versus i.v. colistin (seven observational cohort or case-contro

278 be delivered into the blood circulation via i.v. injection, recharged by 400-nm photoexcitation ligh

279 r adrenaline, noradrenaline, or cortisol via i.v. infusion for 48 h.

280 nosa, isolated from a patient, was given via i.v. catheter to pigs to induce severe sepsis.

281 ncing in xenograft and orthotopic tumors via i.v. injection or aerosol inhalation, respectively.

282 inally enhanced susceptibility to lethal VSV i.v. infection.

283 tions, we compared the efficacy of 12 weekly i.v. infusions of PerT-GUS versus native GUS on (i) deli

284 Horses were i.v. injected with NPHV containing plasma.

285 Mice were i.v. infected with a recombinant adenovirus, and within

286 C57BL/6 mice were i.v. injected with adeno-associated viral vectors encodi

287 ve rats received three weekly sessions where i.v. injected Lipo-DOX was combined with FUS-BBBD; an ad

288 Blue FCF increased bladder capacity, whereas i.v. administration did not.

289 In this study, we assessed whether i.v. administration of oxLDL-induced apoptotic DCs (apop

290 y almost an order of magnitude compared with i.v. delivery with substantially lower plasma concentrat

291 ntrations of drug to the tumor compared with i.v. delivery.

292 reater tumor growth inhibition compared with i.v. FOLFIRINOX.

293 e improved anticancer activity compared with i.v. Taxotere, observed in the metastatic lung cancer mo

294 tumor site was seen with IT-IC compared with i.v.-IC.

295 sculature, achieved by pretreating mice with i.v. liposome-encapsulated clodronate, significantly att

296 imaged with [(18)F]-FAC PET/CT and MRI with i.v. contrast.

297 up was compared with mice injected once with i.v. or i.p. TDM.

298 ing (8-15 days) compared with that seen with i.v. dosing (0.5-4 days).

299 with IT-IC compared with those treated with i.v.-IC or control mice.

300 Treatment with i.v. bscEGFRvIIIxCD3 yielded extended survival in mice w